M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.37 USD 0.85% Market Closed
Market Cap: 117.3m USD
Have any thoughts about
MDxHealth SA?
Write Note

MDxHealth SA
Investor Relations

MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. The company is headquartered in Herstal, Liege. The company went IPO on 2006-06-26. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Michael K. McGarrity
CEO & Executive Director
No Bio Available
Mr. Ron Kalfus CPA
Chief Financial Officer
No Bio Available
Mr. Joseph Sollee J.D., LLM
Executive VP of Corporate Development & General Counsel
No Bio Available
Mr. John A. Bellano
Chief Commercial Officer
No Bio Available
Ms. Miriam Reyes
Executive Vice President of Operations
No Bio Available
Dr. Jason Poole Ph.D.
Chief Scientific Officer
No Bio Available

Contacts

Address
LIEGE
Herstal
CAP Business Center, Rue d'Abhooz 31
Contacts
+3242577021.0
mdxhealth.com